In Vitro Models of Infection for Preclinical Pharmacodynamic Modeling
Pharmacokinetics/Pharmacodynamics as a Tool in Evaluating Antibiotic Efficacy
First Principles: Why Antibiotics Work In Vivo
Important Relationships Between Drug Exposure (Pharmacokinetics) and the MIC
What Can We Learn From In Vitro and Animal Models of Infection to Design Better Clinical Trials?
Differential Surface Analysis as Implemented in MacSynergy (Prichard and Shipman)
“Selected Spectrum Agents” for Resistant Organisms: The Special Case of Combination Therapy Antibiotic “Potentiators”
Animal and In Vitro Models of Infection for PK/PD Studies
One-Compartment In Vitro Pharmacodynamic Model of Infection
PPT Slide
In Vitro Pharmacodynamic Model
In Vitro Models of Infection
Summary: In Vitro and Animal Pharmacokinetic/Pharmacodynamic Models of Infection to Forecast Optimal Regimens for Humans
Home Page: http://www.isap.org/past_activities.htm#ISAP/FDA workshop